Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Non-cash Items (2016 - 2025)

Pharma-Bio Serv filings provide 13 years of Non-cash Items readings, the most recent being $4000.0 for Q4 2025.

  • On a quarterly basis, Non-cash Items fell 98.76% to $4000.0 in Q4 2025 year-over-year; TTM through Oct 2025 was $4000.0, a 98.76% decrease, with the full-year FY2025 number at $4000.0, down 52.18% from a year prior.
  • Non-cash Items hit $4000.0 in Q4 2025 for Pharma-Bio Serv, down from $323370.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $400000.0 in Q4 2022 to a low of $4000.0 in Q4 2025.
  • Median Non-cash Items over the past 5 years was $323370.0 (2024), compared with a mean of $277480.0.
  • Biggest five-year swings in Non-cash Items: increased 22.8% in 2024 and later tumbled 98.76% in 2025.
  • Pharma-Bio Serv's Non-cash Items stood at $396700.0 in 2021, then grew by 0.83% to $400000.0 in 2022, then crashed by 34.17% to $263330.0 in 2023, then grew by 22.8% to $323370.0 in 2024, then tumbled by 98.76% to $4000.0 in 2025.
  • The last three reported values for Non-cash Items were $4000.0 (Q4 2025), $323370.0 (Q4 2024), and $263330.0 (Q4 2023) per Business Quant data.